Theravance Biopharma, Inc.

Theravance Biopharma, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Theravance Biopharma, Inc. is not a good value stock. Theravance Biopharma, Inc. is not very popular among insiders. Theravance Biopharma, Inc. is a mediocre stock to choose.
Log in to see more information.
Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, res...

News

Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?
Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report?

Zacks Investment Research It has been about a month since the last earnings report for Madrigal (MDGL). Shares have added about 1% in that time frame, underperforming the S&P 500.Will the recent positive trend continue...\n more…

Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75
Brokerages Set Theravance Biopharma, Inc. (NASDAQ:TBPH) PT at $13.75

Ticker Report Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH - Get Free Report) have been given a consensus recommendation of "Hold" by the five ratings firms that are covering the stock, MarketBeat Ratings...\n more…

Theravance Biopharma, Inc. (NASDAQ:TBPH) to Post Q3 2024 Earnings of ($0.23) Per Share, Zacks Research Forecasts
Theravance Biopharma, Inc. (NASDAQ:TBPH) to Post Q3 2024 Earnings of ($0.23) Per Share, Zacks Research Forecasts

Ticker Report Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Zacks Research lowered their Q3 2024 EPS estimates for shares of Theravance Biopharma in a report issued on Monday, August 26th. Zacks...\n more…

Q4 2025 EPS Estimates for Theravance Biopharma, Inc. Increased by Analyst (NASDAQ:TBPH)
Q4 2025 EPS Estimates for Theravance Biopharma, Inc. Increased by Analyst (NASDAQ:TBPH)

Ticker Report Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) - Analysts at Zacks Research boosted their Q4 2025 earnings per share estimates for Theravance Biopharma in a research report issued on Monday...\n more…

Theravance Biopharma to Participate in an Upcoming Investor Conference
Theravance Biopharma to Participate in an Upcoming Investor Conference

PR Newswire Theravance Biopharma to Participate in an Upcoming Investor Conference Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, Aug. 27, 2024 DUBLIN, Aug. 27, 2024...\n more…

California State Teachers Retirement System Has $345,000 Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH)
California State Teachers Retirement System Has $345,000 Stake in Theravance Biopharma, Inc. (NASDAQ:TBPH)

Ticker Report California State Teachers Retirement System lowered its position in Theravance Biopharma, Inc. (NASDAQ:TBPH - Free Report) by 17.1% in the first quarter, according to its most recent Form 13F filing...\n more…